GlassScriptPhysician profile
Howard K Nam
NPI 1558365320
$3,088.43
in general payments reported to CMS, 2019-2025
8 companies · $306 in 2025
The $306 reported for 2025 was more than what a typical Facial Plastic Surgery provider received nationally (typical 2025 total: $271).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $422 · 2021: $484 · 2022: $499 · 2023: $102 · 2024: $1,276 · 2025: $306.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,168 · Travel and Lodging: $516.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,167.83 |
| Travel and Lodging | $516.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerin Medical INC. | $1,107.13 | 2019-2024 | |
| Stryker Corporation | $731.90 | 2019-2025 | Scopis Ent, Latera |
| Glaxosmithkline, LLC. | $430.21 | 2024-2025 | Nucala |
| Inspire Medical Systems, INC. | $371.39 | 2021 | |
| Intersect Ent, INC. | $309.42 | 2019-2022 | |
| Depuy Synthes Sales INC. | $88.29 | 2019 | |
| Acclarent, INC | $30.25 | 2023 | Trudi Nav Cable |
| Medtronic, INC. | $19.84 | 2024 | Stealth Autoguide System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Howard Nam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.